NCT02089295

Dose Proportionality Study Of PF-00345439 Formulation Under Fed Conditions

An Open-label, Randomized, Single-dose, Three-way Crossover Study to Evaluate the Dose Proportionality of 5 Mg, 20 Mg and 40 Mg of PF-00345439 Formulation K Under Intermediate-fat Fed Conditions in Healthy Volunteers

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 18 (actual)
• Sponsor: Pain Therapeutics · Industry
• Sex: All
• Age: 18 Years – 55 Years
• Healthy volunteers: Accepted

Summary

To evaluate the dose proportionality of 5 mg, 20 mg and 40 mg of PF 00345439 formulation under fed conditions in healthy volunteers.

Conditions

• Healthy

Interventions

Type	Name	Description
DRUG	Oxycodone	One capsule of 5 mg PF-00345439 Formulation K, single dose, under fed conditions
DRUG	Oxycodone	One capsule of 20 mg PF-00345439 Formulation K, single dose, under fed conditions
DRUG	Oxycodone	One capsule of 40 mg PF-00345439 Formulation K, single dose, under fed conditions

Timeline

• Start date: 2014-04-01
• Primary completion: 2014-06-01
• Completion: 2014-06-01
• First posted: 2014-03-17
• Last updated: 2016-04-04

Locations

2 sites across 1 country: United States